101 related articles for article (PubMed ID: 22694172)
21. HIV Vaccine Trials: Ethical, Psychological, and Psychological-Social Aspects (1991-1996).
Giami A; Linard F
J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S51-S58. PubMed ID: 30222705
[TBL] [Abstract][Full Text] [Related]
22. Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations.
Kilmarx PH; Ramjee G; Kitayaporn D; Kunasol P
AIDS; 2001; 15 Suppl 5():S73-9. PubMed ID: 11816177
[No Abstract] [Full Text] [Related]
23. Communication, recruitment and enrolment in the preventative and therapeutic phase I clinical trial against HIV/AIDS based on the recombinant HIV-1 Tat protein.
Luzi AM; Gallo P; Colucci A; Marcotullio S; Bellino S; Longo O; Ensoli B
AIDS Care; 2011 Aug; 23(8):939-46. PubMed ID: 21390884
[TBL] [Abstract][Full Text] [Related]
24. Global HIV cohort studies among injecting drug users and future vaccine trials.
Woratanarat T
J Med Assoc Thai; 2006 Jul; 89(7):1064-79. PubMed ID: 16881444
[TBL] [Abstract][Full Text] [Related]
25. The use of Zairian children in HIV vaccine experimentation: a cross-cultural study in medical ethics.
Nairn TA
Annu Soc Christ Ethics; 1993; ():223-43. PubMed ID: 12568073
[No Abstract] [Full Text] [Related]
26. Circumcision and HIV prevention research: an ethical analysis.
Lie RK; Emanuel EJ; Grady C
Lancet; 2006 Aug; 368(9534):522-5. PubMed ID: 16890839
[No Abstract] [Full Text] [Related]
27. Thorny issues in the ethics of AIDS vaccine trials.
Berkley S
Lancet; 2003 Sep; 362(9388):992. PubMed ID: 14513850
[No Abstract] [Full Text] [Related]
28. Interest in HIV vaccines among injection drug users in Baltimore, Maryland.
Vlahov D; Astemborski J; Solomon L; Galai N; Basarab L; Nelson KE
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S265-8. PubMed ID: 7865315
[TBL] [Abstract][Full Text] [Related]
29. Background morbidity in HIV vaccine trial participants from various geographic regions as assessed by unsolicited adverse events.
Schmidt C; Smith C; Barin B; Bakhtyari A; Bart PA; Bekker LG; Chomba E; Clumeck N; Ho D; Hoosen A; Jaoko W; Kaleebu P; Karita E; Keefer MC; van Lunzen J; McMichael A; Mehendale S; Peters B; Ramanathan VD; Robinson A; Rockstroh J; Vardas E; Vets E; Weber J; Graham BS; Than S; Excler JL; Kochhar S; Ho M; Heald A; Fast PE
Hum Vaccin Immunother; 2012 May; 8(5):630-8. PubMed ID: 22634443
[TBL] [Abstract][Full Text] [Related]
30. Phase I/II trials of preventive HIV vaccine candidates. Dose and schedule: summary.
Gorse GJ
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S141-3. PubMed ID: 7865289
[No Abstract] [Full Text] [Related]
31. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
Thapinta D; Jenkins RA
Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
[TBL] [Abstract][Full Text] [Related]
32. More women and adolescents needed in HIV vaccine trials.
Expert Rev Vaccines; 2004 Oct; 3(5):501-7. PubMed ID: 15485328
[No Abstract] [Full Text] [Related]
33. Participation in two phase II prophylactic HIV vaccine trials in the UK.
Gray K; Legg K; Sharp A; Mackie N; Olarinde F; De Souza C; Weber J; Peters B
Vaccine; 2008 Jun; 26(23):2919-24. PubMed ID: 18450339
[TBL] [Abstract][Full Text] [Related]
34. Stakeholder perspectives on ethical challenges in HIV vaccine trials in South Africa.
Essack Z; Koen J; Barsdorf N; Slack C; Quayle M; Milford C; Lindegger G; Ranchod C; Mukuka R
Dev World Bioeth; 2010 Apr; 10(1):11-21. PubMed ID: 19459900
[TBL] [Abstract][Full Text] [Related]
35. HIV Vaccine Trial participation in South Africa - an ethical assessment.
Moodley K
J Med Philos; 2002 Apr; 27(2):197-215. PubMed ID: 11961697
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of volunteer participants in phase I HIV vaccine trials.
Crumbo CL; Rybczyk GK; Wagner LJ
J Assoc Nurses AIDS Care; 1997; 8(5):59-65. PubMed ID: 9298470
[TBL] [Abstract][Full Text] [Related]
37. New HIV/AIDS vaccine enters phase II trials.
Ahmad K
Lancet Infect Dis; 2005 Mar; 5(3):138. PubMed ID: 15779123
[No Abstract] [Full Text] [Related]
38. HIV vaccine fails in phase 3 trial.
McCarthy M
Lancet; 2003 Mar; 361(9359):755-6. PubMed ID: 12620743
[No Abstract] [Full Text] [Related]
39. Barriers to volunteer enrollment in HIV preventive vaccine clinical research trials: a review of the literature.
Hurley-Rosenblatt A; Dorsen C
J Assoc Nurses AIDS Care; 2011; 22(4):330-4. PubMed ID: 21256768
[No Abstract] [Full Text] [Related]
40. Incentives and disincentives to participate in prophylactic HIV vaccine research.
Jenkins RA; Temoshok LR; Virochsiri K
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 May; 9(1):36-42. PubMed ID: 7712233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
